chevron_leftBack
As of 14 June 2026, GeneDx Holdings Corp. has a market cap of $1.84B USD, ranking #7448 globally and #1754 in the United States.
It ranks #601 in the Healthcare sector, and #61 in the Medical Care Facilities industry.
Key Stats
Market Cap
$1.84BUSD
Enterprise Value
$1.78BUSD
Revenue (TTM)
$427.54MUSD
EBITDA (TTM)
$12.65MUSD
Net Income (TTM)
-$21.02MUSD
EBITDA Margin
3%
Profit Margin
-4.9%
Forward PE
69.0
PS Ratio
4.3
PB Ratio
6.0
EV/EBITDA
141.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Katherine Stueland
open_in_new
Employees
1,300
Founded
2017
Website
genedx.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -4.8% | -7.2% | 11% | -34% | -54% | -44% |
News
Loading...
WGS Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
WGS
GeneDx Holdings Corp Ordinary Shares - Class A
ISIN: US81663L2007
Shares Out.:
Shares Outstanding:
29.688M1
Shares Float:
26.028M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
62.90 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: HCA
|
$96.73B
5K%
|
14.9
|
|
NYSE: LH
|
$21.13B
1K%
|
24.6
|
|
NYSE: THC
|
$15.78B
757%
|
11.6
|
|
NYSE: SOLV
|
$11.53B
526%
|
7.5
|
|
NASDAQ: ENSG
|
$10.89B
491%
|
31.9
|
|
NYSE: UHS
|
$10.25B
457%
|
6.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
ADX: IHC
|
$232.18B
13K%
852.82B AED
|
44.1
|
|
XETRA: FRE
|
$26.55B
1K%
22.97B EUR
|
15.0
|
|
AMS: PHIA
|
$25.45B
1K%
22.02B EUR
|
24.9
|
|
TADAWUL: 4013
|
$22.48B
1K%
84.42B SAR
|
35.2
|
|
MYX: 5225
|
$19.14B
939%
77.85B MYR
|
37.0
|
|
BVMF: RDOR3
|
$16.69B
806%
84.79B BRL
|
18.1
|
chevron_leftBack